Guj. Themis Bio.

40
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE942C01045
  • NSEID: GUJTHEM
  • BSEID: 506879
INR
382.00
-3.4 (-0.88%)
BSENSE

Jun 11, 03:30 PM

BSE+NSE Vol: 47.62 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -11.20% vs 14.45% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -11.60% vs 6.93% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 58.81% vs 30.08% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -17.56% vs 2.06% in Mar 2024

Compare Profit and Loss Results of Guj. Themis Bio.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
150.00
667.00
-517.00
-77.51%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
150.00
667.00
-517.00
-77.51%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
6.00
-7.00
-116.67%
Raw Materials Consumed
25.00
339.00
-314.00
-92.63%
Power & Fuel Cost
26.00
9.00
17.00
188.89%
Employee Cost
11.00
99.00
-88.00
-88.89%
Operating Expenses
8.00
15.00
-7.00
-46.67%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
62.00
-62.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
4.00
28.00
-24.00
-85.71%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
81.00
575.00
-494.00
-85.91%
Operating Profit (PBDIT) excl Other Income
69.00
91.00
-22.00
-24.18%
Other Income
1.00
36.00
-35.00
-97.22%
Operating Profit (PBDIT)
71.00
127.00
-56.00
-44.09%
Interest
0.00
6.00
-6.00
-100.00%
Profit before Depriciation and Tax
70.00
121.00
-51.00
-42.15%
Depreciation
5.00
27.00
-22.00
-81.48%
Profit Before Taxation & Exceptional Items
65.00
94.00
-29.00
-30.85%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
65.00
94.00
-29.00
-30.85%
Provision for Tax
16.00
25.00
-9.00
-36.00%
Profit After Tax
48.00
68.00
-20.00
-29.41%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
191.00
892.00
-701.00
-78.59%
Profit Available for appropriations
240.00
961.00
-721.00
-75.03%
Appropriations
240.00
961.00
-721.00
-75.03%
Equity Dividend (%)
67%
50%
17.00
Earnings Per Share
4.48
6.56
-2.08
-31.71%
Profit And Loss - Net Sales
Net Sales 150.80 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -11.20% vs 14.45% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 69.60 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -11.60% vs 6.93% in Mar 2024

Profit And Loss - Interest
Interest 0.36 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 58.81% vs 30.08% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 48.77 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -17.56% vs 2.06% in Mar 2024